NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.57%93.761.3%$1006.11m
BIIBBiogen Inc.
-0.35%226.391.3%$952.73m
AMGNAmgen Inc.
-2.74%177.471.3%$455.04m
GILDGilead Sciences, Inc.
-0.47%62.950.9%$420.88m
ILMNIllumina, Inc.
0.11%319.033.5%$281.15m
REGNRegeneron Pharmaceuticals, Inc.
-2.81%333.342.6%$259.19m
VRTXVertex Pharmaceuticals Incorporated
0.71%168.161.9%$237.18m
ALXNAlexion Pharmaceuticals, Inc.
0.08%126.012.0%$169.88m
ONCESpark Therapeutics, Inc.
-0.08%110.6211.2%$168.64m
EXASExact Sciences Corporation
0.44%92.2125.3%$159.86m
SRPTSarepta Therapeutics, Inc.
-1.76%116.6414.7%$145.69m
AAgilent Technologies, Inc.
0.99%76.181.6%$128.52m
INCYIncyte Corporation
-0.48%73.962.5%$95.36m
IONSIonis Pharmaceuticals, Inc.
0.44%72.998.3%$93.24m
BMRNBioMarin Pharmaceutical Inc.
0.98%83.164.3%$89.86m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.